Pfizer to acquire obesity treatment start-up Metsera in $10 billion deal

The deal announcement marked the end of the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker of Ozempic and Wegovy.

Leave a Reply

Your email address will not be published. Required fields are marked *

casibom meritbet jojobet meritbet kulisbet kulisbet jojobet jojobet giriş kulisbet kulisbet giriş cratosroyalbet cratosroyalbet giriş jojobet jojobet giriş
gaziantep escort ümraniye escort ataşehir escort kadıköy escort bursa escort bursa escort bursa escort